Peptide Report
TB-500 Peptide Report
Catalog report for TB-500, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$69.99 – $99.99 CAD
Common Uses
People commonly use TB-500 for soft-tissue recovery, flexibility, tendon and ligament support, and training-related repair routines.
How It Works
TB-500 is a synthetic peptide related to thymosin beta-4. It is discussed for actin-binding biology, cell migration, angiogenesis, inflammation balance, and tissue-remodeling pathways involved in soft-tissue recovery.
Storage
Powder form: In lyophilized powder form, TB-500 is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, TB-500 should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full TB-500 protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 5 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 5 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
2.5 mg/mL |
Each U-100 unit = 25 mcg |
| 5 MG vial – 1 mL example |
Add 1 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 50 mcg |
Syringe Conversion
| Reported amount |
5 MG setup |
5 MG setup |
| 500 mcg |
20 units |
10 units |
| 1 mg |
40 units |
20 units |
| 2 mg |
80 units |
40 units |
| 5 mg |
200 units |
100 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 2 mg |
Twice weekly |
Lower loading reports |
| 2.5-5 mg |
Twice weekly |
Most recurring loading range |
| 2-5 mg |
Every two to four weeks |
Maintenance discussions |
Observations
- Community discussions most often centered on soft-tissue recovery, mobility and injury-related goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- TB-500 human safety and dosing are not established; recovery claims are largely extrapolated from preclinical work.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.